Akoya Biosciences, Inc. (AKYA)

Jul 8, 2025 - AKYA was delisted (reason: acquired by QTRX)

1.290

0.00 (0.00%)

Inactive · Last trade price on Jul 7, 2025

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Instruments	42.10M
Instruments Growth	8.96%
Service and Other	29.22M
Service and Other Growth	69.81%
Consumables	24.13M
Consumables Growth	31.31%
Standalone Software	1.18M
Standalone Software Growth	85.69%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
North America	58.28M
North America Growth	38.62%
EMEA	21.80M
EMEA Growth	22.76%
APAC	16.55M
APAC Growth	9.93%